Treace Medical Concepts, Inc. (TMCI)
USD 7.1
(-6.7%)
USD 7.1
(-6.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -34.57 Million | -30.64 Million | -17.19 Million | -4.49 Million | -7.67 Million |
| Net Income | -49.52 Million | -42.81 Million | -20.55 Million | -3.66 Million | -4.26 Million |
| Depreciation & Amortization | 5.35 Million | 2.13 Million | 685 Thousand | 1.21 Million | 793 Thousand |
| Deferred income taxes | 15.98 Million | - | 419 Thousand | 2.14 Million | 145 Thousand |
| Stock-based compensation | 17.35 Million | 8.11 Million | 3.4 Million | 919 Thousand | 815 Thousand |
| Change in working capital | -9.74 Million | -5.8 Million | -1.33 Million | -5.31 Million | -5.3 Million |
| Other non-cash items | -13.99 Million | 7.73 Million | 176 Thousand | 221 Thousand | 147 Thousand |
| Investing Cash Flow | -81.29 Million | -76.51 Million | -2.7 Million | -1.06 Million | -1.21 Million |
| Investments in PPE | -11.45 Million | -14.83 Million | -2.7 Million | -1.06 Million | -1.21 Million |
| Acquisitions | -20 Million | 61.68 Million | - | - | - |
| Investment purchases | -169.86 Million | -63.4 Million | - | - | - |
| Sales/Maturities of investments | 120.02 Million | 1.72 Million | - | - | - |
| Other Investing Activities | -49.84 Million | -61.68 Million | - | - | - |
| Financing Cash Flow | 109.38 Million | 20.8 Million | 107.65 Million | 11.5 Million | 19.73 Million |
| Debt repayment | - | -33.89 Million | -1.78 Million | -20 Million | -19.67 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -13 Thousand | - | - | - | - |
| Common Stock Issuance | 109.39 Million | 2.18 Million | 109.44 Million | 364 Thousand | 68 Thousand |
| Other Financing Activities | -13 Thousand | 52.51 Million | 107.65 Million | 31.13 Million | 39.34 Million |
| Accounts receivables | -9.3 Million | -11.03 Million | -4.22 Million | -4.29 Million | -6.02 Million |
| Accounts payables | 3.16 Million | 4.61 Million | 1.79 Million | 1.33 Million | -236 Thousand |
| Inventory | -9.84 Million | -8.76 Million | -3.08 Million | -3.4 Million | -2.81 Million |
| Other working capital | 6.23 Million | 9.38 Million | 4.19 Million | 1.04 Million | 3.76 Million |
| Cash at beginning of period | 19.47 Million | 105.83 Million | 18.07 Million | 12.13 Million | 1.28 Million |
| Cash at end of period | 12.98 Million | 19.47 Million | 105.83 Million | 18.07 Million | 12.13 Million |
| Capital Expenditure | -11.45 Million | -14.83 Million | -2.7 Million | -1.06 Million | -1.21 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -6.49 Million | -86.36 Million | 87.75 Million | 5.94 Million | 10.85 Million |
| Free Cash Flow | -46.03 Million | -45.48 Million | -19.89 Million | -5.56 Million | -8.88 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.36 Million | -21.2 Million | -18.67 Million | -49.52 Million | -6.28 Million | -17.52 Million |
| Depreciation & Amortization | 1.23 Million | 2.11 Million | 1.9 Million | 5.35 Million | 1.76 Million | 1.56 Million |
| Deferred income taxes | - | - | - | 15.98 Million | -19.61 Million | -367 Thousand |
| Stock-based compensation | 7.9 Million | 6.74 Million | 7.4 Million | 17.35 Million | 5.87 Million | 5.19 Million |
| Change in working capital | 2.42 Million | -3.97 Million | 1.55 Million | -9.74 Million | -1.51 Million | 781 Thousand |
| Other non-cash items | -8.04 Million | 19.42 Million | 1.28 Million | -13.99 Million | 20.29 Million | 838 Thousand |
| Investing Cash Flow | 5.76 Million | 22.43 Million | 3.75 Million | -81.29 Million | 5 Million | 4.59 Million |
| Investments in PPE | -2.86 Million | -1.72 Million | -3.92 Million | -11.45 Million | -2.24 Million | -3.5 Million |
| Acquisitions | - | - | - | -20 Million | -7.25 Million | -8.09 Million |
| Investment purchases | -24.17 Million | - | -28.71 Million | -169.86 Million | -29.79 Million | -19.11 Million |
| Sales/Maturities of investments | 32.8 Million | 24.16 Million | 36.39 Million | 120.02 Million | 37.04 Million | 27.21 Million |
| Other Investing Activities | - | 24.16 Million | 7.68 Million | -49.84 Million | 7.25 Million | 8.09 Million |
| Financing Cash Flow | 8000.00 | 311 Thousand | -185 Thousand | 109.38 Million | 165 Thousand | 159 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 237 Thousand | - | -237 Thousand | -13 Thousand | -13 Thousand | - |
| Common Stock Issuance | -363 Thousand | 311 Thousand | 52 Thousand | 109.39 Million | 178 Thousand | 159 Thousand |
| Other Financing Activities | 134 Thousand | 311 Thousand | -237 Thousand | -13 Thousand | -13 Thousand | 159 Thousand |
| Accounts receivables | 1.2 Million | 2.47 Million | 7.82 Million | -9.3 Million | -13.42 Million | 2.23 Million |
| Accounts payables | 576 Thousand | -3.07 Million | 9.31 Million | 3.16 Million | 3.15 Million | 534 Thousand |
| Inventory | -2.33 Million | -5.41 Million | -6.61 Million | -9.84 Million | 67 Thousand | -3.21 Million |
| Other working capital | 6.92 Million | 2.04 Million | -8.96 Million | 6.23 Million | 8.68 Million | 1.22 Million |
| Cash at beginning of period | 18.18 Million | 9.33 Million | 12.98 Million | 19.47 Million | 7.27 Million | 12.03 Million |
| Cash at end of period | 12.11 Million | 18.18 Million | 9.33 Million | 12.98 Million | 12.98 Million | 7.27 Million |
| Capital Expenditure | -2.86 Million | -1.72 Million | -3.92 Million | -11.45 Million | -2.24 Million | -3.5 Million |
| Effect of forex changes on cash | - | - | - | - | -4.34 Million | -6 Million |
| Net cash flow / Change in cash | -6.07 Million | 8.84 Million | -3.64 Million | -6.49 Million | 5.7 Million | -4.75 Million |
| Free Cash Flow | -14.7 Million | -15.62 Million | -11.14 Million | -46.03 Million | -1.71 Million | -13.01 Million |
KRNV-M
AILIP
6368
9928
4966
SATCH